Q32 Bio Inc. (FIXX) insider trading

By person

28 insiders · 137 transactions

4.4×

Jodie Morrison holds only 4.4 times base salary in stock. $2.86M of shares against $645.60K in salary for 2025.

Salary from the company's own proxy. The shares are what Jodie Morrison last reported holding, valued at $8.32, the price Common Stock was last bought or sold at on the open market here, on 6 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

5AM Ventures IV, L.P. entity

10% owner

—

$37.36M (14)

−$37.36M

6,903,511

$57.44M

+86.7%

Kush Parmar

Director

—

$37.36M (14)

−$37.36M

181,435

$1.51M

—

Orbimed Advisors LLC entity

Director

$15.00M (2)

—

+$15.00M

625,000

$5.20M

—

Diyong Xu

Director

$15.00M (2)

—

+$15.00M

625,000

$5.20M

—

Temasek Holdings (Private) Ltd entity

10% owner

$10.00M (1)

—

+$10.00M

3,220,293

$26.79M

—

Vida Ventures, LLC entity

10% owner

$6.00M (1)

—

+$6.00M

770,845

$6.41M

—

Rock Springs Capital Management LP entity

10% owner

$4.00M (1)

—

+$4.00M

645,845

$5.37M

—

James E Flynn

10% owner

$32.00M (3)

$29.32M (13)

+$2.68M

4,087,305

$34.01M

—

Arthur Tzianabos

Director

—

$2.07M (14)

−$2.07M

7,983

$66.42K

−88.3%

Albert Seymour

See Remarks

—

$1.66M (16)

−$1.66M

150,874

$1.26M

−36.3%

W Bradford Smith

See remarks

—

$1.27M (13) scheduled

−$1.27M

14,219

$118.30K

—

Jodie Pope Morrison

CEO

—

$331.28K (5)

−$331.28K

340,038

$2.83M

—

Siyamak Rasty

Chief Operating Officer

—

$321.78K (2)

−$321.78K

222,707

$1.85M

−6.7%

Timothy P Kelly

Chief Operating Officer

—

$249.86K (10) scheduled

−$249.86K

2,224

$18.50K

—

Lee Kalowski

CFO and President

—

$133.67K (5)

−$133.67K

137,170

$1.14M

—

Shelia M. Violette

Chief Scientific Officer

—

$72.06K (4)

−$72.06K

163,131

$1.36M

+349.7%

Paul Alloway

See Remarks

—

$30.77K (4)

−$30.77K

51,566

$429.02K

+140.3%

Gabriel Cohn

Chief Medical Officer

—

$6.28K (1)

−$6.28K

2,629

$21.87K

—

Michael Lee Blum

Chief Commercial Officer

—

$3.41K (1)

−$3.41K

13,538

$112.63K

+61.1%

Charles Michaud Jr

See Remarks

—

$2.79K (2)

−$2.79K

18,046

$150.14K

+97.4%

Julie Jordan

Chief Medical Officer

—

$2.71K (4) scheduled

−$2.71K

7,496

$62.37K

+197.6%

ARCH Venture Fund VIII, L.P. entity

10% owner

—

11,837,389

$98.48M

+95.1%

Steven Gillis

Director

—

6,068,695

$50.49M

—

Novartis Institutes for BioMedical Research, Inc. entity

10% owner

—

1,979,226

$16.47M

—

Mahendra Shah

Director

—

1,159,742

$9.65M

—

Isaac Manke

Director

—

53,521

$445.28K

—

Jason Campagna

Chief Medical Officer

—

37,500

$311.99K

—

Richard J. Gregory

Director

—

10,806

$89.90K

—

No percentages here. This company's share count has moved by a factor of 2.4 over the window, from 12,197,615 to 29,769,466 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Q32 Bio Inc.

What the insiders did Net selling

By person